ES377725A1 - Improvements in pharmaceutical compositions - Google Patents

Improvements in pharmaceutical compositions

Info

Publication number
ES377725A1
ES377725A1 ES377725A ES377725A ES377725A1 ES 377725 A1 ES377725 A1 ES 377725A1 ES 377725 A ES377725 A ES 377725A ES 377725 A ES377725 A ES 377725A ES 377725 A1 ES377725 A1 ES 377725A1
Authority
ES
Spain
Prior art keywords
water soluble
pharmaceutical compositions
acidic compound
translation
combining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES377725A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp
Original Assignee
Pfizer Corp Belgium
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp filed Critical Pfizer Corp Belgium
Publication of ES377725A1 publication Critical patent/ES377725A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)

Abstract

A method of preparing a pharmaceutical tablet suitable for oral administration, characterized by combining a water soluble salt of a pharmacologically active acidic compound and a water soluble excipient having a buffering action at a pH above that at which the acidic compound precipitates of the aqueous solution. (Machine-translation by Google Translate, not legally binding)
ES377725A 1969-03-20 1970-03-20 Improvements in pharmaceutical compositions Expired ES377725A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB04670/69A GB1291281A (en) 1969-03-20 1969-03-20 Improvements in pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES377725A1 true ES377725A1 (en) 1972-10-16

Family

ID=10045462

Family Applications (1)

Application Number Title Priority Date Filing Date
ES377725A Expired ES377725A1 (en) 1969-03-20 1970-03-20 Improvements in pharmaceutical compositions

Country Status (10)

Country Link
BE (1) BE747656A (en)
DE (1) DE2013039A1 (en)
DK (1) DK128674B (en)
ES (1) ES377725A1 (en)
FI (1) FI51653C (en)
FR (1) FR2035118B1 (en)
GB (1) GB1291281A (en)
IL (1) IL34089A (en)
NL (1) NL143419B (en)
SE (1) SE379284B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2115116C3 (en) * 1970-03-27 1982-04-15 Sankyo Co., Ltd., Tokyo Lubricants and process for their manufacture
US3969524A (en) * 1974-08-13 1976-07-13 Hoffmann-La Roche Inc. Stable amoxicillin dosage form
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
DE2965732D1 (en) * 1978-12-08 1983-07-28 Beecham Group Plc Pharmaceutical composition comprising a water soluble salt of amoxycillin and polyvinylpyrrolidone, and a vial containing a unit dose of said composition
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2438106A (en) * 1944-06-09 1948-03-23 Wyeth Corp Peroral penicillin compositions
US2864744A (en) * 1955-09-02 1958-12-16 American Home Prod Penicillin in solid dosage unit form
US3131123A (en) * 1959-03-13 1964-04-28 Lab Francais De Therapeutique Enteric tablets and manufacture thereof
GB1276839A (en) * 1968-08-02 1972-06-07 Sandoz Products Ltd Antibiotic compositions

Also Published As

Publication number Publication date
IL34089A0 (en) 1970-05-21
FI51653C (en) 1977-03-10
IL34089A (en) 1974-05-16
FR2035118B1 (en) 1974-08-30
GB1291281A (en) 1972-10-04
SE379284B (en) 1975-10-06
DK128674B (en) 1974-06-17
BE747656A (en) 1970-09-21
DE2013039A1 (en) 1970-09-24
FR2035118A1 (en) 1970-12-18
FI51653B (en) 1976-11-30
NL143419B (en) 1974-10-15
NL7004004A (en) 1970-09-22

Similar Documents

Publication Publication Date Title
CH546779A (en) PROCESS FOR PREPARING PHARMACEUTICALLY ACCEPTABLE SALTS.
ES382842A1 (en) Aryl-substituted piperazinyl-alkylamino-uracils, -uracil ethers and -uracil thioethers and method for their production
ES369624A1 (en) Alkanolamine derivatives
FI50831C (en) A process for preparing an antacid preparation having a high active ingredient content.
ES377725A1 (en) Improvements in pharmaceutical compositions
IL35840A0 (en) Substituted naphthyl alkyl amines and their salts,their preparation and pharmaceutical compositions containing them
ES329052A1 (en) Method of production of pharmaceutical preparations. (Machine-translation by Google Translate, not legally binding)
HU175933B (en) Process for producing 4-hydroxy-3,5-dialkyl-phenyl-propionic acid derivatives and pharmaceutical compositions containing ttem as active agents
ES410825A1 (en) Quinoline derivatives
IL36447A0 (en) Aryloxy-and arylthioalkanoic acids and salts and functional derivatives thereof,their production and pharmaceutical compositions containing them
ES377723A1 (en) Improvements in pharmaceutical compositions
ES401228A1 (en) Pharmaceutical composition containing a zinc-cysteine complex
ES333664A1 (en) A procedure for the preparation of antibacterial agents. (Machine-translation by Google Translate, not legally binding)
ES294897A1 (en) Improvements introduced in the preparation of pharmaceutical compositions in the form of unit dose (Machine-translation by Google Translate, not legally binding)
IL34747A0 (en) Ergonorcornine,its 1-methyl derivative and their salts,their preparation and pharmaceutical compositions containing them
NL164552C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION; FORMED PHARMACEUTICAL PREPARATION; METHOD FOR PREPARING MEDICINAL COMPOUNDS.
IL37586A (en) Indolylacetic acid derivatives and salts thereof,processes for their preparation and pharmaceutical compositions containing the same
GB1125349A (en) Soluble salts of ellagic acid
ES386130A1 (en) Aminoethanesulfonic acid derivative
IL30488A0 (en) Pharmaceutical compositions comprising as an active ingredient p-benzoylphenylacetic acid,o-benzoylphenylacetic acid or salts thereof
ES394364A1 (en) Crystalline kanamycin tetrahydrochloride
IL31294A (en) (hexafluoro-3,5-xylyl)-anthranilic acid and its salts,their preparation,and pharmaceutical compositions containing them
NL173241C (en) PHARMACEUTICAL PREPARATION IN CAPSULE FORM CONTAINING DANTROLENE.
ES375563A1 (en) Pharmaceutical compositions
ES294928A1 (en) A procedure to prepare a liquid and stable composition of tetracycline (Machine-translation by Google Translate, not legally binding)